TransEnterix (TRXDW) Stock Price, News & Analysis

Company Overview

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

Key Stats

• Today's Range: $0.15 to $0.15
• 50-Day Range: $0.15 to $0.15
• 52-Week Range: $0.12 to $0.18
• Volume: N/A
• Average Volume: 8,250 shs
• Market Capitalization: $21.42 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TRXDW Stock Analysis - Frequently Asked Questions

How have TRXDW shares performed this year?

TransEnterix's stock was trading at $0.15 at the start of the year. Since then, TRXDW stock has increased by 0.0% and is now trading at $0.15.
View the best growth stocks for 2025 here.

How were TransEnterix's earnings last quarter?

TransEnterix, Inc. (OTCMKTS:TRXDW) announced its quarterly earnings data on Thursday, November, 5th. The medical instruments supplier reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to the consensus estimate of $0.73 million. TransEnterix had a negative net margin of 2,149.15% and a negative trailing twelve-month return on equity of 83.74%.

How do I buy shares of TransEnterix?

Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/05/2020
• Today: 5/27/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TRXDW
• CIK: 876378
• Web: www.transenterix.com
• Phone: +1-919-7658400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($4.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$154.20 million
• Net Margins: -2,149.15%
• Pretax Margin: N/A
• Return on Equity: -83.74%
• Return on Assets: -64.94%

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 3.24
• Quick Ratio: 2.30

Sales & Book Value

• Annual Sales: $8.53 million
• Price / Sales: 2.51
• Cash Flow: $0.11 per share
• Price / Cash Flow: 1.40
• Book Value: $2.68 per share
• Price / Book: 0.06

Miscellaneous

• Outstanding Shares: 142,777,000
• Free Float: N/A
• Market Cap: $21.42 million
• Optionable: Not Optionable
• Beta: 2.56